Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Behavioral Intervention with financial rewards and coaching

Participants will receive variable financial incentives based on their engagement with the continuous glucose monitor and meeting diabetes treatment goals. In addition, they will participate in three motivational interviewing sessions focused on their diabetes management. Participants will continue to receive their diabetes treatment as usual.

BEHAVIORAL

Control

Participants will only receive a continuous glucose monitor, which they may engage with as desired and no further intervention. Participants in the control group will continue to receive their diabetes treatment as usual.

Trial Locations (1)

64108

RECRUITING

University of Missouri - Kansas City School of Medicine, Kansas City

All Listed Sponsors
lead

University of Missouri, Kansas City

OTHER